Webinar: Emerging Research and Implications of Cannabis - Clinical and Mental Health Implications, Part II
Event information
Dates: October 20, 2021
Location: Virtual
About this event
12:00–1:30 p.m. (EDT)
This webinar is a continuation of Clinical and Mental Health Implications, Part I. It builds on the themes of clinical and health implications, looking at the impact of legalization on associated health and mental health risks.
This webinar showcases research seeking to understand the potential for cannabis as clinical treatment for various mental and physical conditions (e.g., depression, autism, concussions and post-traumatic stress disorder), and across different populations.
Presenters Include:
- Dr. David Hodgins, Professor, University of Calgary
- Dr. Benicio Frey, Associate Professor, McMaster University
- Dr. Kevin Shield, Independent Scientist, Centre for Addiction and Mental Health
- Dr. Brian Hutton, Director and Senior Scientist, Ottawa Hospital Research Institute
- Dr. Kim Corace VicePresident, Innovation & Transformation, Royal Ottawa Mental Health Centre
- Dr. Phil Tibbo, Professor, Dalhousie University
This webinar is part a series on Emerging Research and Implications of cannabis. The series highlights cannabis research projects funded by CCSA and the Mental Health Commission of Canada that address the impact of legalization on policy, non-medical cannabis use and the mental health of people from various communities and diverse populations living in Canada. Questions on the webinar series should be directed to Karen Pacheco at kpacheco@ccsa.ca.